Cargando…
Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center
Heart transplant is the optimal treatment for selected patients with end-stage heart failure. Immunosuppression after heart transplantation has significantly reduced the incidence of rejection and improved patient outcomes with the routine use of calcineurin inhibitors. Antimetabolites and prolifera...
Autores principales: | Chang, David H., Youn, Jong-Chan, Dilibero, Deanna, Patel, Jignesh K., Kobashigawa, Jon A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Heart Failure
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536714/ https://www.ncbi.nlm.nih.gov/pubmed/36263111 http://dx.doi.org/10.36628/ijhf.2020.0034 |
Ejemplares similares
-
The Past, Present and Future of Heart Transplantation
por: Kim, In-Cheol, et al.
Publicado: (2018) -
Arrhythmias After Heart Transplantation: Mechanisms and Management
por: Thajudeen, Anees, et al.
Publicado: (2012) -
Dapsone-Associated Anemia in Heart Transplant Recipients with Normal Glucose-6-Phosphate Dehydrogenase Activity
por: Lor, Kevin W., et al.
Publicado: (2022) -
Heart Transplantation for Advanced Heart Failure
por: Westerdahl, Daniel E., et al.
Publicado: (2019) -
Characteristics, outcomes, and predictors of de novo malignancy after heart transplantation
por: Youn, Jong-Chan, et al.
Publicado: (2022)